These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3292326)

  • 1. Pharmacokinetic model of circulating covalent aggregates of insulin.
    Maislos M; Bialer M; Mead PM; Robbins DC
    Diabetes; 1988 Aug; 37(8):1059-63. PubMed ID: 3292326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free covalent aggregates of therapeutic insulin in blood of insulin-dependent diabetics.
    Robbins DC; Mead PM
    Diabetes; 1987 Feb; 36(2):147-51. PubMed ID: 3542642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The source of the circulating aggregate of insulin in type I diabetic patients is therapeutic insulin.
    Maislos M; Mead PM; Gaynor DH; Robbins DC
    J Clin Invest; 1986 Mar; 77(3):717-23. PubMed ID: 3512601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to covalent aggregates of insulin in blood of insulin-using diabetic patients.
    Robbins DC; Cooper SM; Fineberg SE; Mead PM
    Diabetes; 1987 Jul; 36(7):838-41. PubMed ID: 2438179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.
    Polonsky KS; Licinio-Paixao J; Given BD; Pugh W; Rue P; Galloway J; Karrison T; Frank B
    J Clin Invest; 1986 Jan; 77(1):98-105. PubMed ID: 3511094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients.
    Rave K; Heise T; Pfützner A; Heinemann L; Sawicki PT
    Diabetes Care; 2001 May; 24(5):886-90. PubMed ID: 11347749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels.
    Paolisso G; Sgambato S; Passariello N; Scheen A; D'Onofrio F; Lefèbvre PJ
    Diabetes; 1987 May; 36(5):566-70. PubMed ID: 2883055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous infusions of sulfated insulin normalize plasma glucose levels in pancreatectomized dogs.
    Nomura M; Zinman B; Bahoric A; Marliss EB; Albisser AM
    Diabetes; 1983 Sep; 32(9):788-92. PubMed ID: 6354786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new method for comparing portal and peripheral venous insulin delivery in humans: tolbutamide versus insulin infusion.
    Lewis GF; Steiner G; Polonsky KS; Weller B; Zinman B
    J Clin Endocrinol Metab; 1994 Jul; 79(1):66-70. PubMed ID: 8027255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-molecular-weight aggregates of therapeutic insulin. In vitro measurements of receptor binding and bioactivity.
    Robbins DC; Hirshman M; Wardzala LJ; Horton ES
    Diabetes; 1988 Jan; 37(1):56-9. PubMed ID: 3121417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin.
    de Meijer PH; Lutterman JA
    Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic studies of highly purified human prolactin in normal human subjects.
    Molitch ME; Raiti S; Baumann G; Belknap S; Reichlin S
    J Clin Endocrinol Metab; 1987 Aug; 65(2):299-304. PubMed ID: 3597709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of transperitoneal insulin transport.
    Widerøe TE; Dahl KJ; Smeby LC; Balstad T; Cruischank-Flakne S; Følling I; Simondsen O; Ahlmen J; Jørstad S
    Nephron; 1996; 74(2):283-90. PubMed ID: 8893142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin detemir under steady-state conditions: no accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetes.
    Bott S; Tusek C; Jacobsen LV; Endahl L; Draeger E; Kapitza C; Heise T
    Diabet Med; 2006 May; 23(5):522-8. PubMed ID: 16681561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion.
    Vigili de Kreutzenberg S; Maifreni L; Lisato G; Riccio A; Trevisan R; Tiengo A; Del Prato S
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1023-9. PubMed ID: 2180971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased insulin action and clearance in hyperthyroid newly diagnosed IDDM patient. Restoration to normal with antithyroid treatment.
    Nijs HG; Radder JK; Frölich M; Krans HM
    Diabetes Care; 1989 May; 12(5):319-24. PubMed ID: 2656140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of dawn phenomenon without change in insulin clearance in patients with insulin-dependent diabetes mellitus.
    Campbell PJ; Gerich JE
    Diabetes; 1986 Jul; 35(7):749-52. PubMed ID: 3522315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous somatostatin raises plasma insulin levels in patients with insulin-dependent diabetes mellitus.
    Kollind M; Moberg E; Lins PE; Adamson U
    Horm Metab Res; 1990 Nov; 22(11):581-3. PubMed ID: 1980258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.